FindTrial
Sign In

Minimum effective concentration of ropivacaine for analgesia after cesarean section

Minimum effective concentration of ropivacaine for analgesia after cesarean section

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040415
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-12-07
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia after cesarean section

Interventions

experimental group:ropivacaine Quadratus lumbosum muscle block

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Gestational age between 37-40 weeks; 2. Aged 16 to 40 years; 3. ASA I-II; 4. Inform consent agreed.

Exclusion criteria

Exclusion criteria: 1. Be contraindicated to the anesthesia and analgesia method; 2. Have communication barriers; 3. Bodyweight less than 60 or more than 80kg; 4. patients refuse to participate the research.

Design outcomes

Primary

MeasureTime frame
the NRS scores of cramping pain ;rest pain score;—

Secondary

MeasureTime frame
Bormage scores;the dosage of sufentanil;the usage times of PCA;—

Countries

China

Contacts

Public ContactCao Rong

Chengdu Women's and Children's Central Hospital

1207380443@qq.com+86 13648040896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026